Company intelligence / Profile preview

Cordys Analytics

Utrecht, Utrecht, Netherlandscordys.health ↗

Ownership: Private
Employees: ~8
Development stage: Other

Overview

Cordys Analytics has developed a cloud-based AI diagnostic platform that analyzes electrocardiograms to detect heart disease earlier and more accurately than traditional methods. The company is currently validating its technology in collaboration with leading academic hospitals, supported by multiple grants and seed funding. Early results indicate the AI algorithms outperform existing commercial ECG software in identifying subtle cardiac abnormalities.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware (AI-powered diagnostic platform)
Industry: Physiological Monitoring

Partnerships

University Medical Center Utrecht (UMCU)Meander Medical CenterHospital Clínic de BarcelonaMedicalCSE (Barcelona)

Beyond the preview

Go deeper on Cordys Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cordys Analytics.

Explore the full profile